EP3256150
THYMOSIN ALPHA 1 FOR USE IN TREATMENT OF CYSTIC FIBROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.2.2016EP published:
9.12.2020EP application number:
16714558.0
EPO information:
European Patent Register
Max expiry date:
3.2.2036
Title:
THYMOSIN ALPHA 1 FOR USE IN TREATMENT OF CYSTIC FIBROSIS
Timeline
Today
4.2.2016EP application
9.12.2020EP Publication
Owner
Name:
SciClone Pharmaceuticals International Ltd.Address:
PO Box 309 Ugland House, Grand Cayman KY-1-1104, KY
Inventor
Name:
ROMANI, LuiginaAddress:
Perugia 06123, IT
Name:
GARACI, EnricoAddress:
00199 Rome, IT
Priority
Number:
RM20150056Date:
9.2.2015Country:
IT
Number:
UB20153089Date:
18.9.2015Country:
IT
Classification
Categories:
A61K 38/22, A61P 11/00, A61P 29/00, A61P 1/04, A61P 43/00